Vanderbilt Institute for Medicine and Public Health

Translational Research Forum honors scientific excellence

Vanderbilt University Medical Center’s strength in translational research, which helps “translate” scientific discovery into medical practice, was celebrated recently during the Vanderbilt Translational Research Forum

Fibroids and preterm birth

In a large, prospective study, Vanderbilt researchers found no association between fibroids and any clinical subtype of preterm birth, supporting a reconsideration of the impression that fibroids increase preterm birth risk.

VUMC is pacesetter for national aspirin study

According to an innovative large-scale clinical trial reported last week in the New England Journal of Medicine, a single daily baby aspirin (81 mg) or a single daily adult aspirin (325 mg) are equally safe and effective for prevention of adverse cardiovascular events for patients with established atherosclerotic cardiovascular disease.

Collins takes on new VCC, IMPH leadership roles

Sean Collins, MD, MSci, professor of Emergency Medicine, has taken on new leadership roles in the Vanderbilt Coordinating Center (VCC) and the Vanderbilt Institute for Medicine and Public Health (IMPH).

From organizing ugly sweater parties to serving as a guide for new international students, Jennifer Craker does it all.

“I’ve worked in four institutions with a ton of people in a role like hers, and I’ve never encountered anyone even close to her caliber.”

Hartmann named first Vice President for Research Integration

Katherine Hartmann, MD, PhD, Associate Dean for Clinical and Translational Scientist Development, has been named Vice President for Research Integration for Vanderbilt University Medical Center.

1 2